...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Use of grafts procured from organ transplant recipients.
【24h】

Use of grafts procured from organ transplant recipients.

机译:使用从器官移植接受者那里购买的移植物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Massive intracerebral bleeding may cause brain stem death in transplant (Tx) recipients early or late postTx. We addressed the question as to whether Tx recipients may safely be used as organ donors. In particular, it is feared that exposure to immunosuppressive drugs may render those organs unsuitable for Tx. METHODS: We reviewed two case reports of liver grafts procured from Tx patients. In addition, we conducted a survey within United Kingdom Transplant Support Service Authority (UKTSSA) to delineate the UK experience in that area. RESULTS: Donor 1 was an 50-year-old heart Tx recipient who became brain stem dead due to cerebral bleeding 8 months postTx. His liver was used in an 55-year-old patient with PBC who is alive and well more than 22 months postTx. Donor 2 was a 22-year-old kidney Tx patient who developed cerebral bleeding 4 years postTx. His liver was used in a 65-year-old patient with PBC who is doing well more than 27 months postTx. During the study period of 1989-1995, 13 organs (9 kidneys, 3 hearts, 1 liver) were procured from 6 brain stem dead Tx patients (3 long, 2 heart, and 1 kidney Tx patients). Seven recipients are enjoying satisfactory graft function 1 to 7 years postTx; one kidney Tx recipient was relisted 4 years postTx due to chronic rejection; five functionning grafts were lost to patient death; primary nonfunction was seen in one heart Tx recipient. CONCLUSIONS: Tx patients can be successfully used as organ donors. In particular, chronic exposure to immunosuppression is not per se a contraindication to donation. Tx physicians confronted with the rare and tragic event of brain stem death in a Tx patient should not a priori exclude these patients from donation.
机译:背景:大规模的脑出血可能会在Tx术后早期或晚期导致移植(Tx)受者的脑干死亡。我们解决了有关Tx接收者是否可以安全地用作器官捐赠者的问题。特别地,担心暴露于免疫抑制药物可能会使那些器官不适合Tx。方法:我们回顾了2例从Tx患者获得的肝移植的病例报告。此外,我们在英国移植支持服务局(UKTSSA)内进行了一项调查,以描述英国在该领域的经验。结果:供体1是50岁的心脏Tx接受者,由于Tx后8个月的脑出血而死亡。他的肝脏用于55岁的PBC患者,该患者还活着,并且在Tx术后22个月以上。供体2是22岁的肾脏Tx患者,在Tx后4年发生脑出血。他的肝脏用于一名65岁的PBC患者,该患者在Tx术后27个月内表现良好。在1989-1995年的研究期间,从6例脑干死亡的Tx患者(3例长,2例心脏和1例肾脏Tx患者)获得了13个器官(9个肾脏,3个心脏,1个肝脏)。 Tx术后1至7年,有7位受体的移植功能令人满意。由于慢性排斥反应,一名肾Tx受体在Tx后4年被重新列出;五例功能性移植物因患者死亡而丢失;一位心脏Tx接受者发现原发性无功能。结论:Tx患者可以成功地用作器官供体。特别地,长期暴露于免疫抑制作用本身并不是捐赠的禁忌症。 Tx医师在Tx患者中面临罕见的脑干死亡悲剧性事件,不应事先排除这些患者的捐赠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号